EAST MILLSTONE, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) — Envigo International Holdings, Inc. (“Envigo”), a leading provider of nonclinical contract research services and research models, announced today that the Transaction Agreement with Avista Healthcare Public Acquisition Corp. (“AHPAC”) has been terminated by mutual agreement, due to unfavorable market conditions.
Envigo provides mission-critical products and research services for pharmaceutical, crop protection, and chemical companies as well as universities, governments, and other research organizations. The Company is founded on the principle that research partnerships depend on unmatched expertise, unwavering dedication to customer service, and shared goals. Envigo is committed to helping customers realize the full potential of their products and research which contribute to enhancing the lives of people and animals as well as protecting the environment. With over 3,300 employees worldwide, Envigo provides comprehensive scientific expertise and a full service offering in non-clinical research and development, research models and services, regulatory consulting, and analytical support to customers. Envigo’s corporate headquarters are located in New Jersey.
For enquiries please contact: